Ferran Nadeu received his PhD from the University of Barcelona. He is a post-doctoral researcher at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). He has published 48 articles in top journals in the field of cancer genomics and hematology (H index: 15, total citation count: 1086), being the first and corresponding author in 2 of them (in Nature Communications and Blood journals), 6 as first author, and 6 as second author. He has participated in national and international meetings, such as the annual meetings of the American Society of Hematology (ASH) and the Euroepan Hematology Association (EHA). Besides, he has participated as invited speaker in the European Research Initiative on CLL (ERIC) workshop and the annual meeting of the Sociedad Española de Hematología y Hemoterapia (SEHH). He has also served as a referee for the EHA 2020 Annual Meeting as well as for different scientific journals. Besides of these research merits, Ferran Nadeu has been the leading force in the development of a new bioinformatic algorithm called IgCaller, which is currently under licensing to be used in the diagnostic routine of chronic lymphocytic leukemia. Ferran Nadeu has been recently awarded with three recognized research grants from the American Association for Cancer Research (AACR), the European Hematology Association (EHA), and the Lady Tata Memorial Trust. His research focuses on understanding the subclonal heterogeneity and (epi)genomic determinants of leukemia and lymphoma initiation and progression through the use of novel methodologies and bioinformatic tools.